Taking the sickle cell drug hydroxyurea during or shortly before pregnancy does not appear to cause specific issues in newborns, according to the first prospective study of pregnancies involving hydroxyurea exposure. The study was presented at the 67th ASH Annual Meeting and Exposition held 6–9 December, in Orlando, Florida.
from Medical Xpress - latest medical and health news stories https://ift.tt/BWZVilR
